8:30-9:15am–Case Presentations: Glaucoma

9:15-10:00am–Grand Rounds: Robert Stamper Lecture: “Optical Coherence Tomography, Fundus Imaging and Artificial Intelligence for Glaucoma”, Dr. Joel Schuman, MD

1. Demonstrate the utility of artificial intelligence in OCT image and data analysis.
2. Identify the advantages and disadvantages of advances in OCT technology.
3. Describe the potential utility of AI with fundus imaging in low and middle income countries.

Disclosures:  Presenter Dr. Joel Schuman, MD has the following financial relationships to disclose:
Advisor-Zeiss; Grant or research support-Topcon; Advisor-Heidelberg Engineering; Stocks or stock options, excluding diversified mutual funds-AEYE Health; Stocks or stock options, excluding diversified mutual funds-Ocular Therapeutics; Stocks or stock options, excluding diversified mutual funds-Tarsus; Advisor-Alcon (Any division); Advisor-Boehringer Ingelheim Pharmaceuticals, Inc.; Advisor-Johnson & Johnson; Advisor-Merck (Any division); Stocks or stock options, excluding diversified mutual funds-Ocugenix; Stocks or stock options, excluding diversified mutual funds-Opticent; Advisor-Regeneron Pharmaceuticals, Inc.; Executive-RegenTM
Planner Yvonne Ou, MD advises for Oculinea.

Target Audience: Physicians and Advanced Practice Providers.

Accreditation: In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation: UCSF designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This presentation receives support from UCSF’s (non-commercial) Samuel J. Kimura Fund, Transamerica Lecture Fund and Proctor Lecture Fund.